Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Greer

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Chemical Physics Letters|October 2, 2018
Single Quantum Dot Tracking Illuminates Neuroscience at the NanoscaleOleg Kovtun, Ian D Tomlinson, Danielle M Bailey, et al.
Journal of Medicinal Chemistry|February 20, 2004
Nonpeptide luteinizing hormone-releasing hormone antagonists derived from erythromycin A: design, synthesis, and biological activity of cladinose replacement analoguesJohn T Randolph, Philip Waid, Charles Nichols, et al.
The Journal of Biological Chemistry|April 11, 2003
The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonismBjörn Kauppi, Clarissa Jakob, Mathias Färnegårdh, et al.
Biochemistry|January 22, 2003
Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor seriesVincent Stoll, Kent D Stewart, Clarence J Maring, et al.
Annals of Surgical Oncology|October 31, 2022
Conditional Survival Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC CollaborativeEliza W Beal, Shruthi Srinivas, Chengli Shen, et al.
Annals of Surgical Oncology|June 9, 2023
Validation of the AJCC 8th Edition Staging System for Disseminated Appendiceal Cancer Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-institutional AnalysisGopika SenthilKumar, Anai N Kothari, Ugwuji N Maduekwe, et al.
World Journal of Gastrointestinal Oncology|September 1, 2020
Comparison of open and closed hyperthermic intraperitoneal chemotherapy: Results from the United States hyperthermic intraperitoneal chemotherapy collaborativeJennifer L Leiting, Jordan M Cloyd, Ahmed Ahmed, et al.
Annals of Surgical Oncology|October 19, 2020
CRS/HIPEC with Major Organ Resection in Peritoneal Mesothelioma Does not Impact Major Complications or Overall Survival: A Retrospective Cohort Study of the US HIPEC CollaborativeDavid Roife, Benjamin D Powers, Mohammad Y Zaidi, et al.
Annals of Surgical Oncology|October 30, 2019
Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter?Jason T Wiseman, Charles Kimbrough, Eliza W Beal, et al.
Surgical Oncology|January 19, 2021
A multi-institutional analysis of Textbook Outcomes among patients undergoing cytoreductive surgery for peritoneal surface malignanciesJason T Wiseman, Sherif Abdel-Misih, Eliza W Beal, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Chemical Physics Letters|October 2, 2018
Single Quantum Dot Tracking Illuminates Neuroscience at the NanoscaleOleg Kovtun, Ian D Tomlinson, Danielle M Bailey, et al.
Journal of Medicinal Chemistry|February 20, 2004
Nonpeptide luteinizing hormone-releasing hormone antagonists derived from erythromycin A: design, synthesis, and biological activity of cladinose replacement analoguesJohn T Randolph, Philip Waid, Charles Nichols, et al.
The Journal of Biological Chemistry|April 11, 2003
The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonismBjörn Kauppi, Clarissa Jakob, Mathias Färnegårdh, et al.
Biochemistry|January 22, 2003
Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor seriesVincent Stoll, Kent D Stewart, Clarence J Maring, et al.
Annals of Surgical Oncology|October 31, 2022
Conditional Survival Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC CollaborativeEliza W Beal, Shruthi Srinivas, Chengli Shen, et al.
Annals of Surgical Oncology|June 9, 2023
Validation of the AJCC 8th Edition Staging System for Disseminated Appendiceal Cancer Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-institutional AnalysisGopika SenthilKumar, Anai N Kothari, Ugwuji N Maduekwe, et al.
World Journal of Gastrointestinal Oncology|September 1, 2020
Comparison of open and closed hyperthermic intraperitoneal chemotherapy: Results from the United States hyperthermic intraperitoneal chemotherapy collaborativeJennifer L Leiting, Jordan M Cloyd, Ahmed Ahmed, et al.
Annals of Surgical Oncology|October 19, 2020
CRS/HIPEC with Major Organ Resection in Peritoneal Mesothelioma Does not Impact Major Complications or Overall Survival: A Retrospective Cohort Study of the US HIPEC CollaborativeDavid Roife, Benjamin D Powers, Mohammad Y Zaidi, et al.
Annals of Surgical Oncology|October 30, 2019
Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter?Jason T Wiseman, Charles Kimbrough, Eliza W Beal, et al.
Surgical Oncology|January 19, 2021
A multi-institutional analysis of Textbook Outcomes among patients undergoing cytoreductive surgery for peritoneal surface malignanciesJason T Wiseman, Sherif Abdel-Misih, Eliza W Beal, et al.
Pageof 3